CVD and co-morbidities: What are the priorities? 1Nov. 20, 2014 - EPCCS Brussels - Dr Geert-Jan Geersingh - EPCCS 2014
Dr. Geert-Jan Geersing (Utrecht, The Netherlands) considers the flipside of the successes that have been made in reducing cardiovascular mortality: multimorbidity. Co-existing conditions affect prognosis and treatment of cardiovascular diseases. Individual patient data meta-analyses may provide insight in how to manage these complex patients better.